Xconomy’s Digital Events →
GNS Healthcare CEO Colin Hill (left) chats with Xconomy’s Bob Buderi about using big data analysis on a “new path to personalized medicine.”
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Sponsored · Whitepaper
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.